Diagnostic Tests for Osteoporosis – Clinical Use of Bone Turnover Markers

A joint initiative between ECTS and The Mellanby Centre for Bone Research in Sheffield, UK to  offer high quality training for clinicians, allied health professionals and laboratory scientists working in the field of osteoporosis and other metabolic bone diseases.



Friday 6 May 2022
Messukeskus Siipi Conference Centre, Helsinki, Finlande

Workshop Chairs: Richard Eastell (Sheffield, UK), Kaisa Ivaska (Turku, Finland)

 How to participate

The ECTS-Mellanby Training Course will be held on 6 May 2022, during the Pre-Congress day of the ECTS 2022 Annual Congress in Helsinki.


  • € 150,00 for ECTS Members
  • € 200,00 for non Members
  • € 100,00 in combination with ECTS 2022 congress registration

Registration to the Pre-Congress day will give you access to all other sessions of the day, with the exception of the Open Fora.

Visit the Registration Page for more information.


Programme Overview

Full programme available here.


Course overview:

Bone Turnover Markers (BTM) have long been used as diagnostic tests for metabolic bone diseases. In the past 20 years, markers that are more specific to bone have been introduced and have been found to be useful in osteoporosis, particularly for monitoring treatment. This course aims to provide a background to the clinical use of bone turnover markers.


Target audience:

This day-long course is open to clinicians (e.g. endocrinology, rheumatology, care of the elderly and clinical chemistry), laboratory scientists and nurses involved in the clinical management of patients at risk of osteoporotic fractures.


Learning Objectives:

At the end of the course, participants should:

  • understand the process of bone remodelling and how this can be studied using BTM
  • appreciate the methods used for measuring BTM and their sources of variability
  • be able to identify the role of BTM in the diagnosis and monitoring of bone diseases in a number of clinical settings including; osteoporosis, chronic kidney disease, Paget’s disease, osteomalacia, and GIOP
  • be familiar with best practice in the clinical use of BTM


CME Accreditation:

An application will be made to the UEMS EACCME® for CME accreditation of the event.